The largest drug
discovery company
in the CEE region

More

Your integrated drug
discovery partner of choice

More

Developing breakthrough
therapies in oncology

More

Delivering comprehensive
research solutions to biotech
and pharma

More

News See all

boston-photo1

Selvita will be exhibiting at the 5th MassBio CRO/CMO…

Krakow, Poland - December 1, 2016 - Selvita will be exhibiting at the 5th Annual  MassBio CRO/CMO Symposium at the...
More
bg_ena28

Selvita presents posters at 2016 EORTC-NCI-AACR Symposium

Kraków, Poland - November 30, 2016 - Selvita will present posters reporting results from two of its most advanced research programs...
More
wyniki-q3-2016-eng

Selvita shows 26% business growth in Q3 2016

Krakow, Poland – 23 November 2016 – Selvita, the largest drug discovery company in Central and Eastern Europe, has published...
More
japan

Selvita exhibits at 34th Medicinal Chemistry Symposium in Japan

Kraków, Poland - 23 November 2016 - Selvita will participate and exhibit during the upcoming 34th Medicinal Chemistry Symposium, which will...
More
KR151014AB_001

Selvita announces a ten-year laboratory infrastructure development plan

Krakow, Poland – 22 September 2016 - Selvita (WSE:SLV), the largest drug discovery company in Central and Eastern Europe, has...
More

About Selvita

Selvita has two primary focus areas:

– to serve the drug discovery market as a customer centric provider of high quality, integrated drug discovery services and

– as a drug discovery company engaged in the research and development of breakthrough therapies in oncology.

More

Drug Discovery Services

Selvita is a global integrated drug discovery partner for the pharmaceutical and biotechnology industries.

We offer drug discovery support at every stage of the early discovery phase up to the preclinical research phase.

More

REsearch and Development

Selvita is actively engaged in the discovery and development of breakthrough medicines primarily in the area of oncology. 

Our most advanced project is about to enter the clinic in Q4 2016.

More

Investor Relations SLV -0.41 (-1.64%)

Share price 2016-12-05 14:35:05

24.59 PLN More

Careers

We are a multicultural and a multinational company employing professionals from all over the world.

Find out who we’re courrently looking for and what we can offer our employees.

More